MedTrace Logo

Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas

NCT05433935 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2023-01-27

No results posted yet for this study

Summary

This is a prospective, open large cohort study to explore biomarkers for detecting early carcinogenesis of IPMN.

Conditions

  • Intraductal Papillary Mucinous Neoplasm

Interventions

OTHER

Observation

This is an observational study.

Sponsors & Collaborators

  • The Second Hospital of Hebei Medical University

    collaborator OTHER

  • Second Affiliated Hospital of Nanchang University

    collaborator OTHER

  • Meng Chao Hepatobiliary Hospital of Fujian Medical University

    collaborator OTHER

  • Huizhou Municipal Central Hospital

    collaborator OTHER

  • Zhejiang University

    lead OTHER

Principal Investigators

  • Tingbo Liang, PhD · Zhejiang University

Eligibility

Min Age
0 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2032-06-30
Completion
2033-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05433935 on ClinicalTrials.gov